- Sections
- C - Chimie; métallurgie
- C07D - Composés hétérocycliques
- C07D 323/02 - Cycles à cinq chaînons
Détention brevets de la classe C07D 323/02
Brevets de cette classe: 32
Historique des publications depuis 10 ans
|
1
|
1
|
1
|
0
|
1
|
4
|
1
|
2
|
3
|
1
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 18943 |
8 |
| BELLUS Health Inc. | 19 |
5 |
| Bayer Cropscience AG | 2241 |
2 |
| The Johns Hopkins University | 5377 |
2 |
| Medicines for Malaria Venture MMV | 5 |
2 |
| Ranbaxy Laboratories Limited | 453 |
2 |
| The Wistar Institute of Anatomy and Biology | 387 |
2 |
| Merck Patent GmbH | 5909 |
1 |
| Board of Trustees of Michigan State University | 1141 |
1 |
| Dishman Pharmaceuticals and Chemicals Ltd | 12 |
1 |
| Firmenich SA | 1612 |
1 |
| Human Biomolecular Research Institute | 29 |
1 |
| Medicines for Malarial Venture Mmv | 1 |
1 |
| Takasago International Corporation | 406 |
1 |
| Universität Innsbruck | 107 |
1 |
| ExxonMobil Technology and Engineering Company | 676 |
1 |
| Autres propriétaires | 0 |